The eSensor® SARS-CoV-2 test is a qualitative nucleic acid multiplex assay designed to detect SARS-CoV-2 nucleic acid in nasopharyngeal swabs collected in viral transport media.
This test utilizes the design principles of GenMark’s eSensor Respiratory Viral Panel (RVP), which has been recognized as one of the most sensitive RVP assays available1. The eSensor SARS-CoV-2 Test consists of PCR amplification and detection reagents and eSensor SARS-CoV-2 Test cartridges which run on the XT-8 System. The eSensor SARS-CoV-2 Test can provide results for 96 samples in 5 hours; laboratories set up for high-throughput, 96-well plate processing of clinical specimens can process 384 specimens per day.
*This product is distributed according to section IV.C.2 (FDA Notifications) of FDA’s Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency.
To learn more about the SARS-CoV-2 Test* or to schedule a demonstration, contact us at 1.800.373.6767 or email us.
1. Popowitch, E.B, O’Neill, S.S., Miller, M.B. Comparison of Four Multiplex Assays for the Detection of Respiratory Viruses: Biofire FilmArray RP, GenMark eSensor RVP, Luminex xTAG RVPv1 and Luminex xTAG RVP FAST. J. Clin. Microbiol. 13 March 2013, doi: 10.1128/JCM.03368-12.